BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 717508)

  • 1. Evaluation of dexamethasone acetate as a topical ophthalmic formulation.
    Leibowitz HM; Kupferman A; Stewart RH; Kimbrough RL
    Am J Ophthalmol; 1978 Sep; 86(3):418-23. PubMed ID: 717508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium.
    Kupferman A; Leibowitz HM
    Invest Ophthalmol; 1975 Mar; 14(3):252-5. PubMed ID: 1116925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of derivatization of the bioavailability of ophthalmic steroids. Development of an in vitro method of evaluation.
    Flint GR; Morton DJ
    Arch Ophthalmol; 1984 Dec; 102(12):1808-9. PubMed ID: 6548906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit.
    Kaufman HE; Varnell ED; Toshida H; Kanai A; Thompson HW; Bazan NG
    Am J Ophthalmol; 2001 May; 131(5):643-6. PubMed ID: 11336941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A topical nitric oxide-releasing dexamethasone derivative: effects on intraocular pressure and ocular haemodynamics in a rabbit glaucoma model.
    Galassi F; Masini E; Giambene B; Fabrizi F; Uliva C; Bolla M; Ongini E
    Br J Ophthalmol; 2006 Nov; 90(11):1414-9. PubMed ID: 16914472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD; Comstock TL; Cavet ME
    Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of local corticosteroid therapy on ophthalmic tonus and ocular hydro- and hemodynamics in experimental inflammatory pathology].
    Chaĭka LA; Povolotskaia VA
    Eksp Klin Farmakol; 1995; 58(3):62-4. PubMed ID: 7663304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topically applied steroids in corneal disease. I. The role of inflammation in stromal absorption of dexamethasone.
    Cox WV; Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1972 Sep; 88(3):308-13. PubMed ID: 5053256
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological equivalence of ophthalmic prednisolone acetate suspensions.
    Kupferman A; Leibowitz HM
    Am J Ophthalmol; 1976 Jul; 82(1):109-13. PubMed ID: 937444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of fluorometholone into the cornea and aqueous humor.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1975 Jun; 93(6):425-7. PubMed ID: 1131082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and corneal anti-inflammatory effect of topical suprofen.
    Leibowitz HM; Ryan WJ; Kupferman A; DeSantis L
    Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):628-31. PubMed ID: 3957583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effectiveness of fluorometholone in inflammatory keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1975 Oct; 93(10):1011-4. PubMed ID: 1180749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate.
    Stewart RH; Smith JP; Rosenthal AL
    Curr Eye Res; 1984 Jun; 3(6):835-9. PubMed ID: 6375979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison.
    Naageshwaran V; Ranta VP; Toropainen E; Tuomainen M; Gum G; Xie E; Bhoopathy S; Urtti A; Del Amo EM
    Int J Pharm; 2022 Mar; 615():121515. PubMed ID: 35091006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits.
    Patane MA; Schubert W; Sanford T; Gee R; Burgos M; Isom WP; Ruiz-Perez B
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):760-9. PubMed ID: 23844757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular penetration of dexamethasone sodium phosphate via soft contact lenses].
    Goto S; Fujiwara H; Egi K; Katayama T; Suzuki T
    Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):254-7. PubMed ID: 2788978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chlorhexidine acetate on the corneal penetration of sorbitol from an arnolol formulation in the albino rabbit.
    Ashton P; Diepold R; Platzer A; Lee VH
    J Ocul Pharmacol; 1990; 6(1):37-42. PubMed ID: 2362159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with alpha-chymotrypsin-induced ocular hypertension.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):322-8. PubMed ID: 11981648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.